{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T13:03:04Z","timestamp":1777294984103,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP18H02586"],"award-info":[{"award-number":["JP18H02586"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP18K06749"],"award-info":[{"award-number":["JP18K06749"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19K16447"],"award-info":[{"award-number":["JP19K16447"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.tox.2021.152903","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T11:11:13Z","timestamp":1629457873000},"page":"152903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Evaluation on epithelial-mesenchymal state and microRNAs focusing on isolated alveolar epithelial cells from bleomycin injured rat lung"],"prefix":"10.1016","volume":"461","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2162-6769","authenticated-orcid":false,"given":"Masashi","family":"Kawami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinnosuke","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Kadekaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuki","family":"Akai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Konaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2082-5766","authenticated-orcid":false,"given":"Ryoko","family":"Yumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2865-3129","authenticated-orcid":false,"given":"Mikihisa","family":"Takano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2021.152903_bib0005","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s12282-020-01207-8","article-title":"Characteristics of interstitial lung disease in patients from post-marketing data on metastatic breast cancer patients who received abemaciclib in Japan","volume":"28","author":"Chen","year":"2021","journal-title":"Breast Cancer"},{"key":"10.1016\/j.tox.2021.152903_bib0010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fphar.2019.00388","article-title":"Therapeutic targeting of fibrotic epithelial-mesenchymal transition\u2013an outstanding challenge","volume":"10","author":"Fintha","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tox.2021.152903_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-018-0841-9","article-title":"Human alveolar epithelial cells type II are capable of TGF\u03b2-dependent epithelial-mesenchymal-transition and collagen-synthesis","volume":"19","author":"Goldmann","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.tox.2021.152903_bib0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12935-017-0407-9","article-title":"miR-484 suppresses proliferation and epithelial-mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells","volume":"17","author":"Hu","year":"2017","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.tox.2021.152903_bib0025","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.4049\/jimmunol.171.10.5470","article-title":"Eosinophils and T lymphocytes possess distinct roles in bleomycin-induced lung injury and fibrosis","volume":"171","author":"Huaux","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2021.152903_bib0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s43152-020-00022-9","article-title":"Origin of myofibroblasts in lung fibrosis","volume":"1","author":"Hung","year":"2020","journal-title":"Curr. Tissue Microenviron. Rep."},{"key":"10.1016\/j.tox.2021.152903_bib0035","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s11095-007-9426-x","article-title":"Comparison of albumin uptake in rat alveolar type II and type I-like epithelial cells in primary culture","volume":"25","author":"Ikehata","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tox.2021.152903_bib0040","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1165\/rcmb.2017-0037MA","article-title":"Unbiased quantitation of alveolar type II to alveolar type i cell transdifferentiation during repair after lung injury in mice","volume":"57","author":"Jansing","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.tox.2021.152903_bib0045","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1165\/rcmb.2017-0096ST","article-title":"An official American thoracic society workshop report: use of animal models for the preclinical assessment of potential therapies for pulmonary fibrosis","volume":"56","author":"Jenkins","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.tox.2021.152903_bib0050","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00408-016-9935-7","article-title":"Methotrexate-induced epithelial-mesenchymal transition in the alveolar epithelial cell line A549","volume":"194","author":"Kawami","year":"2016","journal-title":"Lung"},{"key":"10.1016\/j.tox.2021.152903_bib0055","doi-asserted-by":"crossref","first-page":"152231","DOI":"10.1016\/j.tox.2019.06.002","article-title":"Association of cell cycle arrest with anticancer drug-induced epithelial-mesenchymal transition in alveolar epithelial cells","volume":"424","author":"Kawami","year":"2019","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2021.152903_bib0060","doi-asserted-by":"crossref","first-page":"L109","DOI":"10.1152\/ajplung.00176.2018","article-title":"Flow cytometric analysis of the leukocyte landscape during bleomycin-induced lung injury and fibrosis in the rat","volume":"317","author":"Kloth","year":"2019","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.tox.2021.152903_bib0065","doi-asserted-by":"crossref","first-page":"486","DOI":"10.18433\/jpps31448","article-title":"miR-484: a possible indicator of drug-induced pulmonary fibrosis","volume":"23","author":"Konaka","year":"2020","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.tox.2021.152903_bib0070","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.resinv.2013.09.001","article-title":"Consensus statement for the diagnosis and treatment of drug-induced lung injuries","volume":"51","author":"Kubo","year":"2013","journal-title":"Respir. Investig."},{"key":"10.1016\/j.tox.2021.152903_bib0075","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.apsb.2016.06.010","article-title":"MicroRNAs in idiopathic pulmonary fibrosis: involvement in pathogenesis and potential use in diagnosis and therapeutics","volume":"6","author":"Li","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.tox.2021.152903_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41523-018-0073-7","article-title":"MiR-221\/222 promote epithelial-mesenchymal transition by targeting Notch3 in breast cancer cell lines","volume":"4","author":"Liang","year":"2018","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.tox.2021.152903_bib0085","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3389\/fphar.2018.01430","article-title":"The relative risk and incidence of immune checkpoint inhibitors related pneumonitis in patients with advanced cancer: a meta-analysis","volume":"9","author":"Ma","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tox.2021.152903_bib0090","doi-asserted-by":"crossref","first-page":"L152","DOI":"10.1152\/ajplung.00313.2007","article-title":"Murine models of pulmonary fibrosis","volume":"294","author":"Moore","year":"2008","journal-title":"Am. J. Physiol. - Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.tox.2021.152903_bib0095","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1002\/jcp.27489","article-title":"MicroRNAs and signaling networks involved in epithelial\u2013mesenchymal transition","volume":"234","author":"Musavi Shenas","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.tox.2021.152903_bib0100","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1200\/JCO.2016.68.2005","article-title":"Pneumonitis in patients treated with anti-programmed death-1\/programmed death ligand 1 therapy","volume":"35","author":"Naidoo","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tox.2021.152903_bib0105","doi-asserted-by":"crossref","first-page":"12219","DOI":"10.1111\/jcmm.15853","article-title":"miR-34a-5p attenuates EMT through targeting SMAD4 in silica-induced pulmonary fibrosis","volume":"24","author":"Qi","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.tox.2021.152903_bib0110","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/0960327119881678","article-title":"Lipopolysaccharide induces epithelial\u2013mesenchymal transition of alveolar epithelial cells cocultured with macrophages possibly via the JAK2\/STAT3 signaling pathway","volume":"39","author":"Qin","year":"2020","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.tox.2021.152903_bib0115","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fphar.2015.00254","article-title":"MicroRNAs as potential targets for progressive pulmonary fibrosis","volume":"6","author":"Rajasekaran","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tox.2021.152903_bib0120","doi-asserted-by":"crossref","first-page":"E1475","DOI":"10.1073\/pnas.1117988108","article-title":"Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition","volume":"108","author":"Rock","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tox.2021.152903_bib0125","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/17843286.1995.11718459","article-title":"Epidemiology of interstitial lung disease (ILD) in flanders: registration by pneumologists in 1992-1994","volume":"50","author":"Roelandt","year":"1995","journal-title":"Acta Clin. Belg."},{"key":"10.1016\/j.tox.2021.152903_bib0130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12931-018-0834-8","article-title":"Epithelial mesenchymal transition (EMT): a universal process in lung diseases with implications for cystic fibrosis pathophysiology","volume":"19","author":"Rout-Pitt","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.tox.2021.152903_bib0135","first-page":"83","article-title":"Epithelial-mesenchymal transition in the pathogenesis of idiopathic pulmonary fibrosis","volume":"55","author":"Salton","year":"2019","journal-title":"Med."},{"key":"10.1016\/j.tox.2021.152903_bib0140","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1164\/rccm.200610-1491OC","article-title":"Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis","volume":"176","author":"Serrano-Mollar","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.tox.2021.152903_bib0145","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ajpath.2016.12.020","article-title":"p53 and miR-34a feedback promotes lung epithelial injury and pulmonary fibrosis","volume":"187","author":"Shetty","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tox.2021.152903_bib0150","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/jcm7100356","article-title":"Drug-induced interstitial lung disease: a systematic review","volume":"7","author":"Skeoch","year":"2018","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.tox.2021.152903_bib0155","doi-asserted-by":"crossref","first-page":"ra41","DOI":"10.1126\/scisignal.2001538","article-title":"TRPS1 targeting by miR-221\/222 promotes the epithelial-to-mesenchymal transition in breast cancer","volume":"4","author":"Stinson","year":"2011","journal-title":"Sci. Signal."},{"key":"10.1016\/j.tox.2021.152903_bib0160","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.dmpk.2014.10.007","article-title":"Analysis of TGF-\u03b21- and drug-induced epithelial-mesenchymal transition in cultured alveolar epithelial cell line RLE\/Abca3","volume":"30","author":"Takano","year":"2015","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.tox.2021.152903_bib0165","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1016\/j.xphs.2017.04.002","article-title":"Role of miR-34a in TGF-\u03b21- and drug-induced epithelial-mesenchymal transition in alveolar type II epithelial cells","volume":"106","author":"Takano","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tox.2021.152903_bib0170","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fmed.2017.00118","article-title":"Exploring animal models that resemble idiopathic pulmonary fibrosis","volume":"4","author":"Tashiro","year":"2017","journal-title":"Front. Med."},{"key":"10.1016\/j.tox.2021.152903_bib0175","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.ajpath.2013.06.005","article-title":"Qualitative rather than quantitative changes are hallmarks of fibroblasts in bleomycin-induced pulmonary fibrosis","volume":"183","author":"Tsukui","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tox.2021.152903_bib0180","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.bbadis.2012.11.020","article-title":"Regenerative activity of the lung after epithelial injury","volume":"1832","author":"Vaughan","year":"2013","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.tox.2021.152903_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1465-9921-8-1","article-title":"Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an \u03b1-smooth muscle actin-Cre transgenic mouse","volume":"8","author":"Wu","year":"2007","journal-title":"Respir. Res."},{"key":"10.1016\/j.tox.2021.152903_bib0190","doi-asserted-by":"crossref","DOI":"10.1177\/20587392211014427","article-title":"Mechanism of lipopolysaccharide-mediated induction of epithelial-mesenchymal transition of alveolar type II epithelial cells in absence of other inflammatory cells","volume":"19","author":"Wu","year":"2021","journal-title":"Eur. J. Inflamm."},{"key":"10.1016\/j.tox.2021.152903_bib0195","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.tox.2021.152903_bib0200","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1152\/physiolgenomics.00222.2010","article-title":"Comprehensive microRNA analysis in bleomycin-induced pulmonary fibrosis identifies multiple sites of molecular regulation","volume":"43","author":"Xie","year":"2011","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.tox.2021.152903_bib0205","doi-asserted-by":"crossref","first-page":"516","DOI":"10.18433\/jpps30660","article-title":"Anticancer drug-induced epithelial-mesenchymal transition via p53\/miR-34a axis in A549\/ABCA3 cells","volume":"22","author":"Yamamoto","year":"2019","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.tox.2021.152903_bib0210","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1002\/jcb.26537","article-title":"LncRNA H19 promotes epithelial-mesenchymal transition (EMT) by targeting miR-484 in human lung cancer cells","volume":"119","author":"Zhang","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.tox.2021.152903_bib0215","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejphar.2016.12.003","article-title":"MicroRNAs-mediated epithelial-mesenchymal transition in fibrotic diseases","volume":"796","author":"Zou","year":"2017","journal-title":"Eur. J. Pharmacol."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X21002262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X21002262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:47:07Z","timestamp":1759535227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X21002262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":43,"alternative-id":["S0300483X21002262"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2021.152903","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation on epithelial-mesenchymal state and microRNAs focusing on isolated alveolar epithelial cells from bleomycin injured rat lung","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2021.152903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152903"}}